RecruitingNot ApplicableNCT02701153

Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort


Sponsor

Jonsson Comprehensive Cancer Center

Enrollment

51 participants

Start Date

Feb 3, 2016

Study Type

INTERVENTIONAL

Conditions

Summary

This phase II trial studies the side effects of hypofractionated radiation therapy in treating patients with soft tissue sarcomas prior to surgery. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a condensed, 5-day radiation therapy schedule given before surgery for rectal cancer, to see if it is as effective as standard longer radiation schedules and whether it reduces recovery time and side effects without worsening outcomes. **You may be eligible if...** - You have been diagnosed with rectal cancer that requires pre-surgery radiation therapy - Your cancer is in a stage that is typically treated with radiation before surgery - You are healthy enough to receive radiation and undergo surgery - You have not yet started any radiation treatment for this cancer **You may NOT be eligible if...** - Your cancer has already spread to distant organs (metastatic disease) - You have had previous pelvic radiation - You have serious bowel conditions (such as inflammatory bowel disease) that would make radiation riskier - You are pregnant - You have had previous rectal cancer surgery Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREConventional Surgery

Undergo surgery

RADIATIONHypofractionated Radiation Therapy

Undergo hypofractionated radiation therapy

OTHERLaboratory Biomarker Analysis

Correlative studies

OTHERQuestionnaire Administration

Ancillary studies


Locations(1)

UCLA / Jonsson Comprehensive Cancer Center

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02701153